# Bioniq Health-Tech Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioniq-health-tech-solutions

- Industry: Food
- Headquarters: London, UK
- Website: www.bioniq.com
- Total disclosed funding: $23M
- Latest round: Series B (Jul 16, 2024)
- Investors on record: 3

## About

Bioniq Health-Tech Solutions Ltd, based in the UK, specializes in health and wellness technologies, focusing on personalized nutritional products that enhance individual health through tailored micronutrient blends.Bioniq Health-Tech Solutions Ltd was founded in 2019 and is headquartered in London, UK. The company provides innovative health solutions, pivoting towards personalized nutritional offerings. The founders, Calin Popescu, Constantin Karuzin, and Vadim Fedotov, have a history of entrepreneurship, with Vadim Fedotov currently serving as CEO. Their core offerings include tailored micronutrient blends designed to optimize individual health based on specific needs and lifestyles. The company employs a unique approach that combines scientific research with bio-individuality, allowing customers to receive products that address unique health challenges such as energy levels, immune support, and overall well-being. Bioniq's products are primarily aimed at health-conscious consumers, wellness enthusiasts, and individuals seeking preventive health measures. The company has successfully penetrated markets in Europe, North America, and Asia, catering to a diverse client base that includes both individual consumers and health practitioners.Bioniq generates revenue through a direct-to-consumer model, where customers purchase personalized supplement subscriptions tailored to their health needs. This subscription model allows users to receive regular shipments of their customized products, fostering long-term customer relationships and consistent revenue streams. The company's pricing strategy includes various tiers based on the complexity of the personalized service, ensuring accessibility for a wide range of consumers. Flagship products, which are often highlighted for their unique formulations, play a significant role in driving sales. Overall, Bioniq's transactional structure, built around personalized offerings, positions the company to effectively serve its clientele while maximizing revenue potential through repeat purchases. In March 2026, Herbalife agreed to acquire Bioniq Health-Tech Solutions Limited from OKS Group, HV Capital, Unbound, RTP Global, and Rocket Internet SE for an upfront payment of USD 10 million and will receive additional payment of USD 95 million upon achieving milestones.

## Funding rounds

- Series B, Jul 16, 2024, $15M — HV Capital, Unbound
- Series A, Jan 12, 2021, $7.8M — OKS Group

## Investors

- OKS Group (https://capitalatlas.ai/funds/oks-group) — Series A
- HV Capital (https://capitalatlas.ai/funds/hv-capital) — Series B
- Unbound (https://capitalatlas.ai/funds/unbound) — Series B